FDA label
What is ranolazine used for?
The FDA-approved uses of ranolazine, quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “Ranolazine extended-release tablets is indicated for the treatment of chronic angina.”
Run it in Rivvi
Which 2027 plans near you dropped or restricted ranolazine?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Ranolazine, tablet, film coated, extended release
Indications and Usage, quoted from the label by Torrent Pharma, Inc. (ANDA214035). Cross-references to other label sections are left out.
Ranolazine extended-release tablets is indicated for the treatment of chronic angina.
Ranolazine extended-release tablets may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid lowering therapy, ACE inhibitors, and angiotensin receptor blockers.
Source: DailyMed label, set id d2454377-2abd-4d9f-85f1-12f1adbb10e5, version 1, effective April 15, 2026. NDC 13668-759, one of 41 listings for this product.
Ranolazine, tablet, extended release
Indications and Usage, quoted from the label by Umedica Laboratories USA Inc. (ANDA214551). Cross-references to other label sections are left out.
Ranolazine extended-release tablets is indicated for the treatment of chronic angina.
Source: DailyMed label, set id a624dc7f-921d-4554-a813-f72dca0133c3, version 1, effective August 7, 2026. NDC 60290-055, one of 13 listings for this product.
Questions
What is ranolazine used for?
The FDA label says: “Ranolazine extended-release tablets is indicated for the treatment of chronic angina.”
What drug class is ranolazine?
FDA lists ranolazine in the Anti-anginal established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.